In recent years, many xenobiotics derived from natural products have been shown to undergo extensive metabolism by gut microbiota. Ellagitannins, which are high molecular polyphenols, are metabolized to dibenzo [b,d]pyran-6-one derivativesurolithins. These compounds, in contrast with their parental compounds, have good bioavailability and are found in plasma and urine at micromolar concentrations. In vivo studies conducted for ellagitannin-containing natural products indicate their beneficial health effects towards inflammation and cancer, which are associated with the formation of urolithins. However, the great majority of in vitro experiments that have revealed the molecular mechanisms responsible for the observed effects were conducted for urolithin aglycones. These studies are thus incongruent with the results of pharmacokinetic studies that clearly indicate that glucuronide conjugates are the dominant metabolites present in plasma, tissue and urine. The aim of this study was to isolate and structurally characterize urolithin conjugates from the urine of a volunteer who ingested ellagitannin-rich natural products and to evaluate the potential role of β-glucuronidases-triggered cleavage in urolithin disposition.
Introduction
Accumulating evidence has revealed the diverse effects of the gut microbiota on human health, including nutrition, physiology and host metabolism. In recent years, the metabolic crosstalk between a host and its gut microbiota in modulating the pharmacokinetics and pharmacodynamics of drugs has gained much attention (Klaassen and Cui, 2015; Yip and Chan, 2015) . Many xenobiotics derived from food products and medicinal plant materials have been shown to undergo extensive metabolism by gut microbiota, resulting in the formation of small molecular metabolites that not only are more bioavailable than parental compounds but also reveal interesting pharmacological properties (Kieran and Del Rio, 2015) . One of the most widely studied gut microbiota metabolites of natural products are the urolithins.
These 6H-dibenzo [b,d] pyran-6-one derivatives are produced by gut microbiota from high-molecular-weight polyphenols, namely, the ellagitannins (ETs), which are constituents of various medicinal plants and food products. In contrast with parental ETs, urolithins have good bioavailability and are found in plasma and urine at micromolar concentrations. After absorption, urolithins rapidly undergo Phase II metabolism, resulting in their presence in plasma and tissues mostly in a conjugated form; these metabolites are mainly glucuronides and, to a lesser extent, sulfates.
After absorption in the gut, only traces of non-conjugated compounds were detected in bodily fluids, indicating that conjugation has already taken place in the gut epithelium (Gonzalez-Barrio et al., 2010; Gonzalez-Sarrias et al., 2014; NunezSanchez et al., 2014; Mora-Cubillos et al., 2015; Garcia-Villalba et al., 2016; TomasBarberan et al., 2016) .
In vivo and clinical studies conducted for ET-containing natural products clearly indicate beneficial health effects, especially towards inflammation-associated
This article has not been copyedited and formatted. The final version may differ from this version. DMD # 75200 6 diseases and cancer, which are often connected with the formation and absorption of urolithins within the gut (Larrosa et al., 2010a; Larrosa et al., 2010b; Espin et al., 2013; Tomas-Barberan et al., 2016) . These results are accompanied by in vitro studies for urolithins that unambiguously confirm their anti-inflammatory and antiproliferative activities and reveal the molecular mechanisms that are potentially responsible for the observed effects (Gonzalez-Sarrias et al., 2009; Piwowarski et al., 2014a; Piwowarski et al., 2015; Gonzalez-Sarrias et al., 2016) .
One important issue that has recently been raised is the inconsistency of in vitro bioactivity results compared with in vivo and clinical pharmacokinetic studies.
The great majority of in vitro experiments were conducted for urolithin aglycones, making them incongruent with the results of pharmacokinetic studies that clearly indicate that glucuronide conjugates of urolithins are the dominant metabolites present in plasma, tissues and urine .
Although urolithin glucuronides are the main metabolites detected in bodily fluids, the highly enzymatically active environment of inflammation and cancer sites should be considered, as they have the potential to trigger structural alterations. One of the most common, abundant enzymes at these sites is β-glucuronidase, which is released from infiltrating inflammatory cells and the lysosomes of necrotic cells (Tranoy-Opalinski et al., 2014) . β-glucuronidase is also a characteristic enzyme of Escherichia coli, the bacterial species that is responsible for urinary tract infections, among other disease (Chang et al., 1989) .
The aim of the study was to isolate and structurally characterize the urolithin conjugates from the urine of a volunteer after ingestion of ET-rich natural products and to evaluate whether they undergo cleavage under the influence of β-glucuronidases released by human neutrophils, as well as by various E. coli strains.
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Materials and Methods

Reference Compounds and Chemicals
Standards of urolithin A (UA), iso-urolithin A (iUA), urolithin B (UB) and urolithin C (UC) were isolated from human gut microbiota cultures using a previously described method (Piwowarski et al., 2016) . The purity of examined compounds (≥95%) was confirmed using a UHPLC-DAD-MS n method. Lythrum salicaria herb aqueous extract was prepared as described previously (Piwowarski and Kiss, 2013) .
The chromatogram obtained with UHPLC-DAD-MS n method presenting its ellagitannin profile is provided in Supplemental Data Figure S2 .
Subject and Dosing Procedure
We chose a healthy volunteer (male, aged 30) based on our previous study, which identified the volunteer as possessing microbiota that produce the most diverse pattern of urolithins (Piwowarski et al., 2016) . The volunteer was asked to supplement his diet with products rich in ETs. Pomegranate juice (0.5 L/day), walnuts (30 g/day), hazelnuts (30 g/day) and fresh raspberries (200 g/day) were consumed for five days. The total urine was collected from day 1 to day 5 and stored at -20 °C in a total combined volume of 5.5 L of urine. The study respected the 1964 Declaration of Helsinki for the ethical treatment of human subjects for biomedical research.
UHPLC Analysis of Urine
An SPE Chromabond C 18 Hydra column (Macherey-Nagel, Germany) was preconditioned with 10 mL of MeOH and 10 mL of H 2 O. Fifteen mL of urine was applied to the column and washed with 10 mL of H 2 O before elution with 2 mL of MeOH. The eluate was subjected to UHPLC-DAD-MS n analysis. The EtOAc fraction (2.8 g) was chromatographed on a silica gel 60 (MacheryNagel, Duren, Germany) column (27 cm × 3 cm) eluted with MeOH -CHCl 3 (0:100 → 100:0 v/v in 9 steps) to give 140 fractions pooled into 10 main fractions A 1 -A 10 .
Fractions A 2 +A 3 (91.7 mg) contained UB as the major compound, which was purified using preparative HPLC (31.50-32.00 min, 4 mg).
1 H and 13 C NMR spectra were recorded at 25 °C on a VARIAN VNMRS instrument (300 MHz for 1 H and 75 MHz for 13 C NMR). DMSO-d 6 was used as a solvent. Chemical shifts (δ) are reported in ppm, and coupling constants (J) are reported in Hz. The assignments were based on HSQC and HMBC experiments.
Gut microbiota ex vivo metabolism
Evaluation of the ex vivo metabolism of ellagitannins by the volunteer's gut microbiota was performed as described previously (Piwowarski et al., 2014b) . To acquire anaerobic conditions, a brain heart infusion (BHI), (DIFCO, Detroit, MI, USA) was boiled and immediately cooled before the experiment. Forty mg of Lythrum salicaria L. extract (phytochemically standardized ET source) was dissolved in 1 mL of distilled water and sterilized by filtration through an Ophtalsart hydrophilic syringe filter (0.2 mm) (Sartorius Stedim Biotech GmbH, Germany). One mL of 10% fecal slurry in BHI and 0.5 mL of extract solution were added to 8.5 mL of BHI. The batch cultures were incubated in a sealed container under anaerobic conditions using GENbox anaer sachets (bioMerieux, France) at 37 °C. After 24 h, the batch culture 
Neutrophils Isolation
Peripheral venous blood was taken from four healthy human donors (males, 20-35 years old) at the Warsaw Blood Donation Centre. Donors did not smoke or take any medication. They were clinically confirmed to be healthy, and routine laboratory tests showed values within the normal range. The study conformed to the principles of the Declaration of Helsinki. Neutrophils were isolated with a standard method of dextran sedimentation and subsequent hypotonic lysis of erythrocytes and centrifugation in a Ficoll Hypaque gradient (Piwowarski et al., 2014a) . The purity of neutrophils was >97%, and viability as measured by trypan blue exclusion was >98%.
Deglucuronidation assay: After isolation, neutrophils were resuspended in HBSS (6×10 5 cells/mL) primed with cytochalasin B (5 µg/mL) for 5 min and stimulated with f-MLP (1 µM) for 10 min. The neutrophils were centrifuged (2,000 rpm; 10 min; 4 °C). The supernatant was acidified with lactic acid to pH=5.2 and incubated with GiUA, GUA and GUB at a final concentration of 50 µM. After 24 h, 300 µL reaction mixture was mixed with 400 µL MeOH, subjected to an ultrasonication for 5 min and centrifuged (14000 g, 10 min). The hydrolysis of glucuronides was monitored using a UHPLC-DAD-MS n method. The amount of released β-glucuronidase in supernatants was determined using a human β- ultrasonication and centrifuged (14000 g, 10 min). The hydrolysis of glucuronides was monitored using a UHPLC-DAD-MS n method.
Chromatographic methods
UHPLC-DAD-MS n analyses were performed using a UHPLC-3000 RS system 
Statistical analysis
The results are shown as the mean values ± SEM. The statistical significance of differences between means was determined by one-way ANOVA. For comparison of results between the groups, Tukey's post hoc test was used. Results with p-value < 0.05 were considered statistically significant. All analyses were performed using Statistica 10 software.
Results
Profile of urinary metabolites. UHPLC-DAD-MS/MS analysis has shown that the regular weekly intake of ET-rich products results in secretion of Phase II conjugates of urolithins in urine ( DMD # 75200 13 chromatography, three major glucuronide metabolites were isolated from human urine-GiUA, GUA, GUB (Fig. 1) -as was UB. The structures were determined using 1 H, 13 C NMR, HSQC and HMBC spectra (Table 1 ). All metabolites were identified as β-anomers based on the anomeric H-1 signal appearing at δ 5.0 as a doublet, with a coupling constant near 7 Hz (Pearson et al., 2005) . The downfield shift of H2 and H4 in the GiUA spectrum, compared to to its aglycone (Piwowarski et al., 2016) NMR spectra, which have shown two sets of proton (Fig. 3) and carbon signals. It was impossible to separate these two isomers using available chromatographic methods. However, complete proton and carbon assignments were performed based on 2D NMR spectra (Table 1) .
Gut microbiota ex vivo metabolism. In all, iUA, UA, UB, and UC were determined in the volunteer's gut microbiota cultures (Fig. 2B) . Their identities were confirmed by comparison of retention times, UV and MS data with standard substances. The most abundant peak was observed for iUA, while only small amounts of UA were detected.
Deglucuronidation by human neutrophils. Neutrophils isolated from human
peripheral venous blood were primed with cytochalasin B and subsequently stimulated with f-MLP to release the azurophilic granules containing β-glucuronidase.
The supernatant pH was adjusted to 5.2 -which is known to be an optimal value for
This article has not been copyedited and formatted. The final version may differ from this version. (Ho, 1985) . Incubation of GiUA, GUA and GUB with supernatants resulted in enzymatic cleavage of β-glycosidic bonds and release of the respective aglycones ( Fig. 4A and 5 ). The deglucuronidation process was significantly enhanced when neutrophils were stimulated with cytochalasin B and f-MLP in comparison to untreated cells. When pH was adjusted beyond the optimal values (pH=7.2 in the case of HBSS without lactic acid and pH=3.5 when excessive acidification was applied), deglucuronidation was not observed (data not shown). To evaluate whether β-glucuronidase is responsible for the cleavage, its concentration was determined using an ELISA test. Significantly higher enzyme protein concentrations in supernatants were observed upon stimulation. In addition, differences in the amounts of f-MLP-triggered enzyme release were observed between blood donors (D1-D4) that were strictly correlated with the extent of deglucuronidation (Fig. 4B) . No significant differences in the compounds' susceptibility to enzymatic cleavage were observed.
Deglucuronidation in E. coli cultures. Two reference E. coli strains, NCTC
10538 and ATCC 25922, and 7 clinical isolates (C1-C7) obtained from patients suffering from urinary tract infections were used for examinations. Cultures in Fluorocult VRB Agar plates (Merck) revealed that the strains expressed different abilities to hydrolyze 4-methylumbelliferyl-β-D-glucuronide (MUG) (Fig. 6) . The most intense blue fluorescence from free 4-methylumbelliferone was observed in the E. coli C1 strain, while E. coli NCTC 10538 and C6 showed no fluorescence. Incubation of GiUA, GUA and GUB with selected E. coli strains and isolates resulted in deglucuronidation and release of the respective aglycones (Fig. 7 , Supplemental
Data Figure S1 ). No hydrolysis was observed when compounds were incubated in BHI medium without bacteria inoculation. The most active strain was C1, which was This article has not been copyedited and formatted. The final version may differ from this version. 
Discussion
The chosen volunteer was assigned as metabotype B (producing iUA, UA, and UB) . In addition to Phase II metabolites, the respective aglycones were also detected in urine. They were not only found when total collected urine was analyzed ( Fig. 2A ) but also when samples were analyzed immediately after collection (data not shown), which excludes the possibility of their formation through storage-triggered hydrolysis. The most abundant metabolite was GUA, while ex vivo cultures of the volunteer's gut microbiota showed the reverse pattern, with significant dominance of iUA. This observed iUA dominance was in concordance with previous studies conducted on single ETs using the volunteer's gut microbiota (see volunteer D3 in our previous paper Piwowarski et al., 2016) . This discrepancy could be explained by different metabolic activity in gut microbiota in vivo and ex vivo or by differences in the metabolic and/or elimination pathways between UA and iUA. Although the volunteer's microbiota were able to produce UC, no phase II metabolites of this compound were detected in urine.
Phase II metabolites of urolithins were isolated from human urine and their structures were fully described based on the NMR spectra. NMR data for GUA and GUB were in concordance with 1 H spectra for compounds obtained through chemical synthesis (Lucas et al., 2009; Gonzalez-Sarrias et al., 2013 showed that the distribution of this compound and its conjugated metabolites among different organs reached concentrations up to 1050 ng/g (Seeram et al., 2007) .
Although urolithin conjugates were clearly shown to dominate in plasma, tissues and urine following the administration of ET-rich natural products, the majority of in vitro studies have focused on non-conjugated molecules. Only a few studies investigate urolithin Phase II metabolites, the majority of which have shown significant in vitro and in silico decreases in activity for conjugated compounds. The
Phase-II metabolism of urolithins in different cell lines is considered a mechanism of cancer cells resistance against urolithins, due to their conversion to glucuronide conjugates, which were shown to exert significantly lower anti-proliferative activity (Adams et al., 2010; Dellafiora et al., 2013; Gonzalez-Sarrias et al., 2014; GonzalezSarrias et al., 2015; Larrosa et al., 2006; Sala et al., 2015) . This is the first report of a reversed process of deglucuronidation. Differences in anti-inflammatory activity between GUA and UA were only shown by Gimenez-Bastida et al., 2012, while urolithin methylation was shown to lead to significant activity loss or decrease (Piwowarski et al., 2014a) . Numerous pathological conditions, including inflammatory processes and tumors, are known to be associated with significantly increased levels of extracellular β-glucuronidase. Human β-glucuronidase is a lysosomal enzyme that accumulates at inflammation sites and in tumor microenvironments due to release from infiltrating neutrophils and macrophages as well as necrotic cells (Tranoy-Opalinski et al., 2014) . Mitochondrial respiration defects observed in inflamed and neoplastic tissues lead to aerobic glycolysis-also known as the Warburg effect-resulting in pH decreases due to elevated lactic acid production that creates optimal conditions for β-glucuronidase activity (Warburg, 1956a; Warburg, 1956b; Palsson-McDermott and O'Neill, 2013) . As a result, autophagy impairment leads to mitochondrial dysfunction that induces β-glucuronidase activity (Ishisaka et al., 2013) , while damaged mitochondria, similar to bacteria, release formyl peptides that can signal using formyl peptide receptor-1 (FPR1) to trigger an immune response (Sun et al., 2016) .
In vitro and in vivo
We have clearly shown that urolithin conjugates are cleaved by β-glucuronidase, which is released by neutrophils from azurophilic granules upon stimulation of FPR1. The optimum pH, obtained by acidification with lactic acid, was necessary for enzymatic cleavage, as it was not observed in either the environment of pure HBSS or acidified to pH=3.5. Previous studies conducted for luteolin glucuronide have revealed that its deconjugation is triggered by stimulated
neutrophils. An increased ratio of aglycone/glucuronide was also observed in the plasma of LPS-treated rats (Shimoi et al., 2001) . The β-glucuronidase released by macrophages was shown to be essential for activation of quercetin glucuronide conjugates. Its enzymatic activity, which requires acidic pH, was promoted by increased secretion of lactate in response to mitochondrial dysfunction (Kawai, 2014) . Although the highest concentration of urolithin Phase II metabolites were observed in urine, no studies have yet been conducted regarding the impact of these compounds on ailments associated with urinary tract disorders. Uropathogenic
Escherichia coli (UPEC) is the main cause of urinary tract infections, which produces significant amounts of β-glucuronidase (Vinacur et al., 1974; Helander and Dahl, 2005; McLellan and Hunstad, 2016 conjugates and liberated toxic free hydroquinone, which is known to possess antibacterial activity (Siegers et al., 2003) Table 1 . NMR spectroscopic data (300 MHz, DMSO-d 6 ) for GiUA, GUA and GUB. 
